EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Arix Bioscience's enterprise value is £82.78 Mil.
Arix Bioscience's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was £0.08 Mil. Therefore, Arix Bioscience's EV-to-Revenue for today is 1,075.09.
The historical rank and industry rank for Arix Bioscience's EV-to-Revenue or its related term are showing as below:
LSE:ARIX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 81.06 Med: 151.17 Max: 310.71
Current: 928.97
During the past 7 years, the highest EV-to-Revenue of Arix Bioscience was 310.71. The lowest was 81.06. And the median was 151.17.
LSE:ARIX's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 8.18
vs LSE:ARIX: 928.97
As of today (2024-05-25), Arix Bioscience's stock price is £1.42.
Arix Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.00. Therefore, Arix Bioscience's PS Ratio for today is .
Arix Bioscience EV-to-Revenue Historical Data
The historical data trend for Arix Bioscience's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Arix Bioscience's EV-to-Revenue
For the Biotechnology subindustry, Arix Bioscience's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arix Bioscience's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Arix Bioscience's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Arix Bioscience's EV-to-Revenue falls into.
Arix Bioscience's current Enterprise Value is £82.78 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arix Bioscience's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was £0.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arix Bioscience's share price for today is £1.42.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was £0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arix Bioscience EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Arix Bioscience's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:ARIX has been successfully added to your 